Invesco Biotechnology & G... (PBE)
NYSEArca: PBE
· Цена в реальном времени · USD
94.22
+0.29 (0.31%)
На закрытии: Aug 13, 2026, 3:37 PM
Invesco Biotechnology & Genome ETF (PBE) ETF Price, Holdings & Analysis
0.31% (1D)
| Покупка | 92.96 |
| Рыночная капитализация | n/a |
| AUM | 281.95M |
| NAV | 93.86 |
| Бета | 0.79 |
| EPS (TTM) | н/д |
| P/E (TTM) | 25.36 |
| Акций в обращении | 4.55M |
| Дата запуска | Jun 23, 2005 |
| Продажа | 95.11 |
| Объём | 55,293 |
| Сред. объём (20Д) | 22,217 |
| Открытие | 95.01 |
| Пред. закрытие | 93.93 |
| Диапазон дня | 94.08 - 94.67 |
| Диапазон за 52 недели | 67.05 - 95.01 |
| Активы | н/д |
| Коэффициент расходов | 0.58% |
О PBE
The fund generally will invest at least 90% of its total assets in securities that comprise the underlying index. The underlying index was composed of common stocks of U.S. biotechnology and genome companies. These companies are engaged principally in the research, development, manufacture and marketing and distribution of various biotechnological products, services and processes, etc. It is non-diversified.
Класс активов Equity
Тикер PBE
Дата запуска Jun 23, 2005
Управляющая компания Invesco
Сайт Страница фонда
Биржа NYSEArca
Топ-10 активов 46.14% активов
| Название | Тикер | Вес |
|---|---|---|
| Regeneron Pharmaceut... | REGN | 5.47% |
| Amgen Inc | AMGN | 5.22% |
| Caredx Inc | CDNA | 5.03% |
| Vertex Pharmaceutica... | VRTX | 4.98% |
| Royalty Pharma PLC C... | RPRX | 4.93% |
| Biogen Inc | BIIB | 4.78% |
| Gilead Sciences Inc | GILD | 4.43% |
| United Therapeutics ... | UTHR | 4.07% |
| Bio-techne Corp | TECH | 3.73% |
| Illumina Inc | ILMN | 3.50% |
Дивиденды Дивидендная доходность 1.64%
| Дата отсечки | Сумма | Дата выплаты |
|---|---|---|
| Jun 22, 2026 | $0.8110 | н/д |
| Mar 23, 2026 | $0.0820 | н/д |
| Dec 22, 2025 | $0.4200 | н/д |
| Sep 22, 2025 | $0.2340 | н/д |
| Jun 23, 2025 | $0.1300 | н/д |
